treatment approaches for braf v600e mutant metastatic colorectal cancer
Published 4 months ago • 239 plays • Length 1:17Download video MP4
Download video MP3
Similar videos
-
2:28
the evolving treatment paradigm for braf v600e-mutant mcrc
-
1:26
novel treatment strategies for braf v600e-mutant nsclc
-
1:45
breakwater: encorafenib plus cetuximab in patients with braf v600e-mutant mcrc
-
2:18
prognosticating braf-mutant mcrc
-
2:56
treating braf v600e-mutant nsclc with dabrafenib and trametinib
-
1:24
fire-4.5: folfoxiri plus either bevacizumab or cetuximab as 1l treatment of braf v600e-mutant mcrc
-
5:19
targeting braf v600e in metastatic colorectal cancer: where are we today?
-
4:19
targeting braf in metastatic crc
-
4:54
case 1: braf-mutated metastatic colorectal cancer
-
0:54
treatment options in refractory metastatic colorectal cancer
-
1:18
how braf v600e-mutated crc is treated differently than other cancers
-
20:52
what is the optimal therapy for braf mutant metastatic colorectal cancer?
-
7:50
case 1: treatment of braf-mutated colorectal cancer
-
1:03
advances in targeted therapies for colorectal cancer
-
6:01
beacon trial: triplet therapy in braf v600e–mutated mcrc
-
4:25
fire-4.5: folfoxiri plus either bevacizumab or cetuximab in mcrc
-
8:16
encorafenib & binimetinib cetuximab for untreated braf v600e-mutant metastatic colorectal cancer
-
6:06
colorectal cancer debate: first line braf v600e - targeted triplet
-
17:51
how to approach the patient with a braf mutant tumor